Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities-Reference-Cited by-同舟云学术

Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities

Published:2016-03 Issue:3 Volume:34 Page:122.e1-122.e7
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Haake Scott M.,Brooks Samira A.,Welsh Eric,Fulp William J.,Chen Dung-Tsa,Dhillon Jasreman,Haura Eric,Sexton Wade,Spiess Philippe E.,Pow-Sang Julio,Rathmell W. Kimryn,Fishman Mayer

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. ACS. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.

2. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma;Mian;J Urol,2002

3. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma;Motzer;J Clin Oncol,1999

4. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

5. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies;Rini;Lancet Oncol,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal muscle and visceral adipose radiodensities are pre‐surgical, non‐invasive markers of aggressive kidney cancer;Journal of Cachexia, Sarcopenia and Muscle;2024-01-24

2. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma;European Urology;2023-08

3. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer;Urologic Clinics of North America;2023-05

4. Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients;Cancer Medicine;2023-04-20

5. A comparison of analytic approaches for investigating the obesity paradox in kidney cancer;Cancer Causes & Control;2023-02-14